Industry Symposium by GE Healthcare
SY 14 - What do advancements in cancer treatment really mean for radiology?
Lectures
1
SY14 - Industry Symposium by GE Healthcare: What do advancements in cancer treatment really mean for radiology?
60:44GE Healthcare
SY 14-1
5 min
Introduction
Valérie Vilgrain, Clichy / France
SY 14-2
15 min
How new and innovative oncology therapies interface with diagnostic practice
Guiseppe Curigliano, Milan / Italy
Learning Objectives
Cancer patients have potential risk of nephrotoxicity
An appropriate risk assessment should be done at baseline
Potential toxicity of anticancer treatment and of contrast medium agents should be considered
An appropriate risk assessment should be done at baseline
Potential toxicity of anticancer treatment and of contrast medium agents should be considered
SY 14-3
15 min
The Reciprocal Dance between Kidney and Cancer
Angel De Francisco, Santander / Spain
Learning Objectives
Kidney Injury in Patients with Cancer: Why oncology patients are more vulnerable and susceptible?
The concept of hidden kidney failure in oncology patients- What radiologists should know
Contrast induced oxidative stress in kidneys with medullar hypoxia : an increased risk of renal damage in cancer patients
The concept of hidden kidney failure in oncology patients- What radiologists should know
Contrast induced oxidative stress in kidneys with medullar hypoxia : an increased risk of renal damage in cancer patients
SY 14-4
15 min
The Role of Advanced Imaging in Surgical Oncology
Elliot K. Fishman, Baltimore / United States
Learning Objectives
define the role of advanced imaging including 3D post processing in oncology today
define the importance of the imaging in Oncology multidisciplinary conferences
define the potential impact of AI (artificial intelligence) in Oncology in the future
define the importance of the imaging in Oncology multidisciplinary conferences
define the potential impact of AI (artificial intelligence) in Oncology in the future
SY 14-5
10 min
Q&A